This webinar will include a discussion of 15 currently enrolling clinical trials in ALS as well as other topics, including: Radicut, Masitinib, Tirasemtiv, Brainstorm, NP001, Ibudilast, Edison Pharma, GM604, among others. The discussion will last about 90 minutes. |